Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Apr 12;4(5):505-8.
doi: 10.1002/ccr3.516. eCollection 2016 May.

Case report: false positive elevated serum-galactomannan levels after autologous hematopoietic stem cell transplantation caused by oral nutritional supplements

Affiliations
Case Reports

Case report: false positive elevated serum-galactomannan levels after autologous hematopoietic stem cell transplantation caused by oral nutritional supplements

Tobias Rachow et al. Clin Case Rep. .

Abstract

Positive galactomannan tests in patients who underwent chemotherapy without any clinical signs of a fungal infection should lead the clinician to consideration of a false-positive test result. Oral nutritional supplements may be a cause, especially in the case of concomitant disturbance of the gastrointestinal mucosal barrier because of mucositis.

Keywords: Autologous stem cell transplantation; enteral nutrition; galactomannan; invasive fungal infection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trends of C‐reactive protein (triangle‐symbols and solid line) and serum‐galactomannan (dots and broken line) after stem cell retransfusion: the C‐reactive protein levels increased with fever in neutropenia and normalized after initiation of an effective antibacterial therapy; the level of serum‐galactomannan increased even after neutropenic reconstitution (on day 12) and fell after advising the patient to quit consuming the hypercaloric drinks.

Similar articles

Cited by

References

    1. Ostrosky‐Zeichner, L. 2012. Invasive mycoses: diagnostic challenges. Am. J. Med. 125(1 Suppl):S14–S24. - PubMed
    1. Maertens, J. A. , Klont R., Masson C., Theunissen K., Meersseman W., Lagrou K., et al. 2007. Optimization of the cutoff value for the Aspergillus double‐sandwich enzyme immunoassay. Clin. Infect. Dis. 44:1329–1336. - PubMed
    1. Arendrup, M. C. , Bergmann O. J., Larsson L., Nielsen H. V., Jarlov J. O., and Christensson B.. 2010. Detection of candidaemia in patients with and without underlying haematological disease. Clin. Microbiol. Infect. 16:855–862. - PubMed
    1. Ellis, M. , Al‐Ramadi B., Bernsen R., Kristensen J., Alizadeh H., and Hedstrom U.. 2009. Prospective evaluation of mannan and anti‐mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J. Med. Microbiol. 58(Pt 5):606–615. - PubMed
    1. Herbrecht, R. , Letscher‐Bru V., Oprea C., Lioure B., Waller J., Campos F., et al. 2002. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J. Clin. Oncol. 20:1898–1906. - PubMed

Publication types

LinkOut - more resources